Product Information
ABILIFY 2 MG TABLET is a brand product labeled by Otsuka America Pharmaceutical Inc., priced at $18.6541 per EA under NDC 59148000613. Its NADAC has been published 510 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the ARIPIPRAZOLE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2 mg/1
Manufacturer
Otsuka America Pharmaceutical Inc.NDC
59148000613
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ARIPIPRAZOLEApproval Type
New Drug (NDA)
FDA Application
NDA021436On Market Since
11/15/2002
Pharmacological Classes
Price Statistics
The NADAC for ABILIFY 2 MG TABLET has been published 510 times since Nov 28, 2013, and over the history we have for it it has declined 14.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $18.6541 per EA |
|---|---|
| All-time high | $29.1101 (Apr 15, 2015) |
| All-time low | $18.6249 (Dec 17, 2025) |
| 52-week high | $18.6541 |
| 52-week low | $18.6249 |
| Median price | $28.5163 |
| Average price | $25.9729 |
| Largest weekly change | -34.3% (Apr 17, 2024) |
| Weeks tracked | 510 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ABILIFY 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ABILIFY 2 MG TABLET, manufactured by Otsuka America Pharmaceutical Inc., is $18.6541 per EA (NDC 59148000613), effective Jun 24, 2026.
How has the price of ABILIFY 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for ABILIFY 2 MG TABLET has declined 14.6%. It has been tracked across 510 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ABILIFY 2 MG TABLET?
Since Nov 28, 2013, the NADAC for ABILIFY 2 MG TABLET has ranged from a low of $18.6249 (Dec 17, 2025) to a high of $29.1101 (Apr 15, 2015), with a median of $28.5163 per EA.
Are there cheaper alternatives to ABILIFY 2 MG TABLET?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, ARIPIPRAZOLE 2 MG TABLET, is $0.1036 per EA — about 99% below ABILIFY 2 MG TABLET.
Who manufactures ABILIFY 2 MG TABLET?
ABILIFY 2 MG TABLET (NDC 59148000613) is labeled by Otsuka America Pharmaceutical Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification